events or deaths (EFS)

mEC - (neo)adjuvant (NA) metastatic/advanced - esophageal cancer (mEC) mEC - (neo)adjuvant (NA)

versus placebo
nivolumab alone vs. placebo 1 certainty unassessablestatistically conclusive-34%